Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Hum Genet
2018 Mar 01;1023:505-514. doi: 10.1016/j.ajhg.2018.01.023.
Show Gene links
Show Anatomy links
Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2.
Lassuthova P, Rebelo AP, Ravenscroft G, Lamont PJ, Davis MR, Manganelli F, Feely SM, Bacon C, Brožková DŠ, Haberlova J, Mazanec R, Tao F, Saghira C, Abreu L, Courel S, Powell E, Buglo E, Bis DM, Baxter MF, Ong RW, Marns L, Lee YC, Bai Y, Isom DG, Barro-Soria R, Chung KW, Scherer SS, Larsson HP, Laing NG, Choi BO, Seeman P, Shy ME, Santoro L, Zuchner S.
???displayArticle.abstract???
Although mutations in more than 90 genes are known to cause CMT, the underlying genetic cause of CMT remains unknown in more than 50% of affected individuals. The discovery of additional genes that harbor CMT2-causing mutations increasingly depends on sharing sequence data on a global level. In this way-by combining data from seven countries on four continents-we were able to define mutations in ATP1A1, which encodes the alpha1 subunit of the Na+,K+-ATPase, as a cause of autosomal-dominant CMT2. Seven missense changes were identified that segregated within individual pedigrees: c.143T>G (p.Leu48Arg), c.1775T>C (p.Ile592Thr), c.1789G>A (p.Ala597Thr), c.1801_1802delinsTT (p.Asp601Phe), c.1798C>G (p.Pro600Ala), c.1798C>A (p.Pro600Thr), and c.2432A>C (p.Asp811Ala). Immunostaining peripheral nerve axons localized ATP1A1 to the axolemma of myelinated sensory and motor axons and to Schmidt-Lanterman incisures of myelin sheaths. Two-electrode voltage clamp measurements on Xenopus oocytes demonstrated significant reduction in Na+ current activity in some, but not all, ouabain-insensitive ATP1A1 mutants, suggesting a loss-of-function defect of the Na+,K+ pump. Five mutants fall into a remarkably narrow motif within the helical linker region that couples the nucleotide-binding and phosphorylation domains. These findings identify a CMT pathway and a potential target for therapy development in degenerative diseases of peripheral nerve axons.
Anderson,
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
2006, Pubmed
Anderson,
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
2006,
Pubmed Arystarkhova,
Isoform-specific monoclonal antibodies to Na,K-ATPase alpha subunits. Evidence for a tissue-specific post-translational modification of the alpha subunit.
1996,
Pubmed Bublitz,
In and out of the cation pumps: P-type ATPase structure revisited.
2010,
Pubmed de Carvalho Aguiar,
Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism.
2004,
Pubmed De Fusco,
Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.
2003,
Pubmed Dobretsov,
Stretch receptor-associated expression of alpha 3 isoform of the Na+, K+-ATPase in rat peripheral nervous system.
2003,
Pubmed Edwards,
Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons.
2013,
Pubmed Fridman,
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis.
2015,
Pubmed Friedrich,
ATP1A2 Mutations in Migraine: Seeing through the Facets of an Ion Pump onto the Neurobiology of Disease.
2016,
Pubmed Gonzalez,
Innovative genomic collaboration using the GENESIS (GEM.app) platform.
2015,
Pubmed Heinzen,
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.
2012,
Pubmed Holm,
Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models.
2016,
Pubmed Kanai,
Crystal structure of a Na+-bound Na+,K+-ATPase preceding the E1P state.
2013,
Pubmed Lek,
Analysis of protein-coding genetic variation in 60,706 humans.
2016,
Pubmed McGrail,
Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase.
1991,
Pubmed Morth,
A structural overview of the plasma membrane Na+,K+-ATPase and H+-ATPase ion pumps.
2011,
Pubmed Murphy,
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.
2011,
Pubmed Pareyson,
New developments in Charcot-Marie-Tooth neuropathy and related diseases.
2017,
Pubmed Pedersen,
Identification of Asp804 and Asp808 as Na+ and K+ coordinating residues in alpha-subunit of renal Na,K-ATPase.
1997,
Pubmed Philippakis,
The Matchmaker Exchange: a platform for rare disease gene discovery.
2015,
Pubmed Pressley,
Ionic regulation of Na+,K(+)-ATPase expression.
1992,
Pubmed Rossor,
Clinical implications of genetic advances in Charcot-Marie-Tooth disease.
2013,
Pubmed Scherer,
Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
2005,
Pubmed Shy,
Reliability and validity of the CMT neuropathy score as a measure of disability.
2005,
Pubmed Skre,
Genetic and clinical aspects of Charcot-Marie-Tooth's disease.
1974,
Pubmed Timmerman,
Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success.
2014,
Pubmed Todt,
Rare missense variants in ATP1A2 in families with clustering of common forms of migraine.
2005,
Pubmed
,
Xenbase Toustrup-Jensen,
Relationship between intracellular Na+ concentration and reduced Na+ affinity in Na+,K+-ATPase mutants causing neurological disease.
2014,
Pubmed Vanmolkot,
Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions.
2003,
Pubmed Zhang,
Stimulation-induced Ca(2+) influx at nodes of Ranvier in mouse peripheral motor axons.
2016,
Pubmed
